PRR22 Antibodies

Santa Cruz Biotechnology offers a broad range of PRR22 Antibodies for research focused on understanding PRR22 protein functions. PRR22 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PRR22, or proline-rich protein 22, plays essential roles in signal transduction and immune response regulation. PRR22 expression maintains cellular homeostasis and modulates inflammatory responses. Research has shown PRR22's involvement in various biological pathways and cellular mechanisms. Understanding PRR22 function provides valuable insights into autoimmune diseases and cancer development. Investigating PRR22's molecular interactions helps reveal its role in disease progression and potential therapeutic targets. Advanced research techniques using monoclonal antibodies enable precise detection and analysis of PRR22 in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies for PRR22 support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.